These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast. Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030 [TBL] [Abstract][Full Text] [Related]
132. Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction. Brantley SJ; Gufford BT; Dua R; Fediuk DJ; Graf TN; Scarlett YV; Frederick KS; Fisher MB; Oberlies NH; Paine MF CPT Pharmacometrics Syst Pharmacol; 2014 Mar; 3(3):e107. PubMed ID: 24670388 [TBL] [Abstract][Full Text] [Related]
133. Herb-drug interactions: challenges and opportunities for improved predictions. Brantley SJ; Argikar AA; Lin YS; Nagar S; Paine MF Drug Metab Dispos; 2014 Mar; 42(3):301-17. PubMed ID: 24335390 [TBL] [Abstract][Full Text] [Related]
134. Prodrugs of quercetin and resveratrol: a strategy under development. Biasutto L; Zoratti M Curr Drug Metab; 2014 Jan; 15(1):77-95. PubMed ID: 24329110 [TBL] [Abstract][Full Text] [Related]
135. Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin. Chengcheng G; Rui X; Tianheng M; Wei Y; Liqun P Afr Health Sci; 2013 Sep; 13(3):551-5. PubMed ID: 24250287 [TBL] [Abstract][Full Text] [Related]